SK
Surendra Kumar Tripathi
About Surendra Kumar Tripathi
Data last updated:
Surendra Kumar Tripathi is a Director at Castlemed Life Sciences Private Limited (since 2025), Director at Lanceli Lifesciences Private Limited (since 2024) and Designated Partner at Hdfs Biotech Llp (since 2020). The companies operate in Pharma, Biotechnology and Trading. Earlier, Surendra Kumar Tripathi was a Director at Hdfs Pharmaceuticals Private Limited (2022–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Sep 2025 | 2025 | Active | ||
| Director | 29 Nov 2024 | 2024 | Active | ||
| Designated Partner | 31 Dec 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Dec 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Surendra Kumar Tripathi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhawal Prajapati | 10562720 | Castlemed Life Sciences Private Limited , Lanceli Lifesciences Private Limited | Director |
| Ashutosh Tripathi | 10856074 | Lanceli Lifesciences Private Limited | Director |
| Kripa Shanker Tripathi | 10340717 | Lanceli Lifesciences Private Limited | Director |
| Habib Ahmad | 09016221 | Hdfs Biotech Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surendra Kumar Tripathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surendra Kumar Tripathi
Surendra Kumar Tripathi currently holds 3 directorships: Castlemed Life Sciences Private Limited (Director, since 12 Sep 2025); Lanceli Lifesciences Private Limited (Director, since 29 Nov 2024); Hdfs Biotech Llp (Designated Partner, since 31 Dec 2020).
Surendra Kumar Tripathi was first appointed on 31 Dec 2020 as Designated Partner at Hdfs Biotech Llp. The most recent appointment on record is 12 Sep 2025 at Castlemed Life Sciences Private Limited.
Surendra Kumar Tripathi held 1 earlier board appointment: Hdfs Pharmaceuticals Private Limited (Director, 29 Dec 2022 to 30 Mar 2025).
The current boards of Surendra Kumar Tripathi's companies include Dhawal Prajapati (Castlemed Life Sciences Private Limited), Ashutosh Tripathi (Lanceli Lifesciences Private Limited), Kripa Shanker Tripathi (Lanceli Lifesciences Private Limited), Habib Ahmad (Hdfs Biotech Llp).